Few technologies have attracted the public interest like the use of stem cells for treating a variety of diseases. This interest has been driven from numerous reports of exciting or "groundbreaking" preclinical data in animal models. Learn how the exciting potential based on these results is actually being translated into early clinical studies as well as advanced-stage programs targeting specific diseases. You will hear from researchers, clinicians and companies during this session on the challenges of interpreting preclinical stem cell research and moving forward into clinical studies so the hope of cell therapy can soon be realized.

• Provide several different perspectives on advancements in the stem cell field
• Highlight the opportunity that stem cell therapies represent to the translational medicine field
• Show how an early-stage concept can be progressed and moved forward in the clinic